[{"address1": "North Tower", "address2": "6th Floor 333 Ludlow Street", "city": "Stamford", "state": "CT", "zip": "06902", "country": "United States", "phone": "888 729 1206", "fax": "201 421 2010", "website": "https://www.genedx.com", "industry": "Health Information Services", "industryKey": "health-information-services", "industryDisp": "Health Information Services", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GeneDx Holdings Corp., a genomics company, provides personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company accelerate the use of genomics and leverage clinical data to enable precision medicine as the standard of care. It utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients. The company offers genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.", "fullTimeEmployees": 1000, "companyOfficers": [{"maxAge": 1, "name": "Ms. Katherine A. Stueland", "age": 48, "title": "President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 745915, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  Feeley CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 488192, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Olivares Ph.D.", "title": "Chief Product & Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Heidi C. Chen J.D.", "age": 57, "title": "Chief Legal Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jami  Biliboaca", "title": "Head of People Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Kruszka FACMG, M.D., M.P.H.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melanie  Duquette", "title": "Chief Growth Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1735689600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 96.57, "open": 95.53, "dayLow": 85.6, "dayHigh": 95.69, "regularMarketPreviousClose": 96.57, "regularMarketOpen": 95.53, "regularMarketDayLow": 85.6, "regularMarketDayHigh": 95.69, "beta": 2.18, "forwardPE": 168.64151, "volume": 721852, "regularMarketVolume": 721852, "averageVolume": 634044, "averageVolume10days": 706410, "averageDailyVolume10Day": 706410, "bid": 88.98, "ask": 89.82, "bidSize": 300, "askSize": 300, "marketCap": 2455393536, "fiftyTwoWeekLow": 2.85, "fiftyTwoWeekHigh": 98.87, "priceToSalesTrailing12Months": 9.188384, "fiftyDayAverage": 77.9378, "twoHundredDayAverage": 41.924026, "currency": "USD", "enterpriseValue": 2455034368, "profitMargins": -0.31246, "floatShares": 18750327, "sharesOutstanding": 27471400, "sharesShort": 2147875, "sharesShortPriorMonth": 2337626, "sharesShortPreviousMonthDate": 1731628800, "dateShortInterest": 1734048000, "sharesPercentSharesOut": 0.078200005, "heldPercentInsiders": 0.18189, "heldPercentInstitutions": 0.72617996, "shortRatio": 4.09, "shortPercentOfFloat": 0.2059, "impliedSharesOutstanding": 27471400, "bookValue": 7.454, "priceToBook": 11.990877, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -83497000, "trailingEps": -3.09, "forwardEps": 0.49, "lastSplitFactor": "1:33", "lastSplitDate": 1683158400, "enterpriseToRevenue": 9.187, "enterpriseToEbitda": -63.331, "52WeekChange": 25.840841, "SandP52WeekChange": 0.22263205, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "WGS", "underlyingSymbol": "WGS", "shortName": "GeneDx Holdings Corp.", "longName": "GeneDx Holdings Corp.", "firstTradeDateEpochUtc": 1604500200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "2ffa3076-357b-3ae2-a6e2-462cba4425fb", "messageBoardId": "finmb_608642327", "gmtOffSetMilliseconds": -18000000, "currentPrice": 89.38, "targetHighPrice": 118.0, "targetLowPrice": 70.0, "targetMeanPrice": 88.0, "targetMedianPrice": 85.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 116460000, "totalCashPerShare": 4.239, "ebitda": -38765000, "totalDebt": 116101000, "quickRatio": 2.003, "currentRatio": 2.405, "totalRevenue": 267228000, "debtToEquity": 56.773, "revenuePerShare": 10.113, "returnOnAssets": -0.08270001, "returnOnEquity": -0.36401, "freeCashflow": -20056750, "operatingCashflow": -55171000, "revenueGrowth": 0.442, "grossMargins": 0.6086, "ebitdaMargins": -0.14506, "operatingMargins": -0.10113, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-11"}]